Pharmaceutical and biotech companies approve and fund investigator initiated trials to meet a number of clinical objectives while building strong relationships with key opinion leaders. Conducting these types of trials enables pharma to capture insightful data on the performance of their drug products across other therapeutic areas.
Our Investigator Initiated Trial (IIT) Service offers comprehensive oversight and management of all clinical supply activities for a portfolio of Investigator Initiated Trials. We enable Sponsors to maintain or increase their support of IITs while keeping their primary focus on higher priority studies.
As a Client, you will determine the level of involvement that you want, from a total “hands-off” approach to one that requires approval of certain key supply chain activities. Contact us to discuss how we can assist you with your clinical trial.
Benefits of our IIT Service offering include:
From protocol development to study close out, our IIT Team is committed to supporting your IITs by reducing complexities for both you and the investigator sites, while ensuring sites receive premium service levels.
Let’s connect. We’re ready to help you with your clinical trial.